POSTER SESSION II Monday, February 13, 2006   —  1:00 - 4:30 PM Exhibit Level DERMATOPATHOLOGY 8 Comparison of UVB Induced Gene Expression Profiles in Whole Skin from Melanoma Patients and Healthy Controls. (351) K Crone, C Soden, M Watson, L Cornelius - Washington University, St. Louis, MO 9 Melastatin (MLSN) Gene Expression In Normal Skin Melanocytes (362) CK Ibrahim, TM Nazir, JS Ross, CE Sheehan, A Slominski, JA Carlson - Albany Medical College, Albany, NY; University of Tennessee, Memphis, TN 10 The Notch Signaling In Melanocytic Nevi And Cutaneous Malignant Melanoma (380) D Massi, F Tarantini, A Franchi, M Paglierani, C Di Serio, S Pellerito, G Leoncini, G Cirino, P Geppetti, M Santucci - University of Florence, Florence, Italy; University of Naples, Italy 11 Expression and Cellular Localization of S100A4 Protein in Melanocytic Lesions (405) BP Wu, WM Klein, S Zhao, H Wu, AJP Klein-Szanto, SR Tahan - Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; Fox Chase Cancer Center, Philadelphia, PA 12 Differenting Spitzoid Melanoma from Spitz Nevus Through CD99 Expression (368) MS King, SJ Porchia, KM Hiatt - University of Arkansas for Medical Sciences, Little Rock, AR 13 Molecular Pathology Of Stage I And II Cutaneous Malignant Melanoma: Study Of The Sentinel Lymph Node. (354) VC Denninghoff, AG Kahn, J Falco, V Trouchot, HP Curutchet, B Elsner - Center for Medical Education and Clinical Investigation, Hospital de Clinicas, University of Buenos Aires Medical School Buenos Aires, Argentina; University of South Alabama Medical Center, Mobile, AL 14 Intracapsular Melanoma In Sentinel Lymph Node Biopsies (339) KO Alsaad, NA Obaidat, DM Ghazarian - University of Toronto and University Health Network, Toronto, ON, Canada 15 Evaluation of Angiogenesis Using VEGF, Microvessel Density and Trombospondin-1 in Cutaneous Malignant Melanomas (357) O Erdem, N Akyurek, I Isik Gonul, F Bir, A Poyraz, L Memis - Gazi University, Ankara, Turkey; Pamukkale University, Denizli, Turkey 16 Expression Of VEGF And Flk-1 In Malignant Melanoma (383) M Niveiro, N Pastor, G Peiro, C Alenda, J Segui, FI Aranda - General Hospital of Alicante, Alicante, Spain 17 Fli-1 expression in Malignant Melanoma (397) E Torlakovic, A Slipicevic, V Florenes, R Chibbar, N Bilalovic - Royal University Hospital, Saskatoon, SK, Canada; The Norwegian Radium Hospital, Oslo, Norway; University Hospital Sarajevo, Sarajevo, Bosnia and Herzegowina 18 Cluster Analysis of Small Tissue Microarray Dataset of Key Differentiation and Progression Antigens in Melanoma Identifies Groups with Differential SMAC Levels (408) Q Zhou, N Chen, J Gong - West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan, China 19 Neutral Endopeptidase (NEP) Overexpression Is Associated With Progression In Malignant Melanoma (MM) And Is A Potential Target Of Treatment. (401) EF Velazquez, M Yancovitz, L Sorhaindo, D Bogunovic, D O'Neill, R Shapiro, A Pavlick, R Berman, N Bhardwaj, J Spira, P Christos, D Nanus, D Polsky, I Osman - NYU School of Medicine, Cornell University Weill Medical College, New York, NY 20 Analysis Of Galectin-3 Expression In Melanocytic Lesions By Tissue Array. Possible Involvement In Tumor Progression (390) VG Prieto, AA Mourad-Zeidan, MM Johnson, AH Diwan, AJF Lazar, SS Shen, JA Reed, A Raz, M Bar-Eli - UT - MD Anderson Cancer Center, The Methodist Hospital, Baylor College of Medicine, Houston, TX; Karmanos Cancer Institute, Wayne State University, Detroit, MI 21 A High-Throughput Study Identifies Epithelial-Mesenchymal Transition As Major Determinant Of The Melanoma Metastatic Capacity (338) SR Alonso, PL Ortiz, L Tracey, B Perez-Gomez, M Pollan, J Linares, S Serrano, AI Saez, L Sanchez, R Pajares, C Ballestin, MA Piris, JL Rodriguez-Peralto - CNIO (Spanish National Cancer Center), HU 12 de Octubre, ISCIII, Madrid, Spain; HU San Cecilio, Granada, Spain 22 Expression Of Dicarbonyl/L-xylulose Reductase (DCXR), A Novel Cell Adhesion Molecule, In Melanocytic Lesions (346) JH Cho-Vega, F Vega, MR Schwartz, VG Prieto - The Methodist Hospital, UT - MDACC, Houston, TX 23 BRAF And C-Kit Copy Number In Mutation Positive Malignant Melanoma (403) C Willmore-Payne, JA Holden, S Hirschowitz, LJ Layfield - University of Utah Health Sciences Center, Salt Lake City, UT; UCLA Center for Health Sciences, Los Angeles, CA 24 Melanocytic Lesions on the Distal Lower Extremity Share Features of Dysplastic Nevi and Melanoma In-Situ (367) I Khalifeh, J Reed, A Lazar, H Diwan, VG Prieto - Detroit Medical Center, Detroit, MI; MD Anderson, Baylor University, Houston, TX 25 The Predictive Value of Lymphatic Invasion Detected by D2-40 Immunostain in the Malignant Melanoma Patients with Positive Lymph Nodes (373) X Lin, S Yan, YL Liu, RS Saad, JF Silverman - Allegheny General Hospital, Pittsburgh, PA 26 Cytokeratin 18 In Melanoma Cells: Assessment With Immunohistochemistry, Western Blot Analysis, In Situ Hybridization, And Reverse Transcription Polymerase Chain Reaction (345) N Chen, YF Wang, J Gong, YT He, Q Zhou - West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan, China 27 Immunohistochemical Expression Of Microtubule Associated Protein-2 (MAP-2) In Eccrine Poroma (407) SX Yan, YL Liu, MT Tung, RS Saad, JF Silverman - Allegheny General Hospital, Pittsburgh, PA 28 Morphological Spectrum Of Eccrine Porocarcinoma (384) F Ogawa, E Arai, M Kuroda, T Moriya, M Fukunaga, M Izumi, H Minato, M Shimizu - Saitama Medical School, Moroyama-machi, Saitama, Japan; Fujita Health University School of Medicine, Houmei, Aichi, Japan; Tohoku University, Graduate School of Medicine, Sendai, Miyagi, Japan; Jikei University Daisan Hospital, Komae, Tokyo, Japan; Tokyo Medical University, Shinjuku-ku, Tokyo, Japan; Kanazawa University, Graduate School of Medical Science, School of Medicine, Kanazawa, Japan 29 Expression Of D2-40 In Eccrine Spiradenoma (406) SX Yan, RS Saad, MT Tung, S Ro-Yim, JF Silverman, YL Liu - Allegheny General Hospital, Pittsburgh, PA 30 Keratin 15 Stem Cell Marker And Other Immunohistochemical Characteristics Of Sebaceous Neoplasms (341) R Bieniek, AJF Lazar, S Lyle - Beth Israel Deaconess Medical Center, Boston, MA; University of Massachusetts Medical School, Worcester, MA; UT MD Anderson Cancer Center, Houston, TX 31 Cytokeratin 7 And 20 Expression In Clear Cell Lesions Of The Skin (385) DA Ostler, AG Perna, D Ivan, JA Reed, AJ Lazar, AH Diwan, R Ghorbani, VG Prieto - University of Texas Health Science Center at Houston Medical School, UT MD Anderson, Baylor College of Medicine, Houston, TX 32 Primary Cuteneous Adenoid Cystic Carcinoma: A Clinicopathologic And Immunohistochemical Study Of 17 Cases. (344) IH Chaudhry, P Ramdial, M MacMenamin, E Calonje - Leeds General Infirmary, Leeds, United Kingdom; Nelson R Mandela School of Medicine and Central Hospital, Durban, South Africa; Dublin Hospital, Dublin, Ireland; St John's Institute of Dermatology, St. Thomas' Hospital, London, United Kingdom 33 Her-2/neu Expression and Gene Amplification in Malignant and Metastasizing Skin Adnexal Tumors (382) JW Nash, D Ivan, VG Prieto, AH Diwan, E Calonje, T Barrett, N Sneige, S Lyle, AJF Lazar - UT-MD Anderson Cancer Center, Houston, TX; St John's Institute of Dermatology, London, United Kingdom; ProPath Laboratories, Dallas, TX; U Massachusetts Medical School, Worcester, MA 34 CD10 and Ep-CAM Expression In Basal Cell Carcinoma, Classical Trichoepithelioma, And Desmoplastic Trichoepithelioma (337) TE Abbott, MD Cole, JW Patterson, MR Wick - University of Virginia Health System, Charlottesville, VA 35 Metastatic Basal Cell Carcinoma Exhibits Reduced Actin and Calponin Expression (398) MC Uzquiano, VG Prieto, AJF Lazar, AH Diwan - University of Texas Medical Center, UT MD Anderson Cancer Center, Houston, TX 36 Potential Therapeutic Utility Of Epidermal Growth Factor Receptor (EGFR) And C-Kit Immunostaining, And Clinicopathologic Profile Of Metastatic Basal Cell Carcinomas (BCC): A Study Of 9 Cases. (379) R Malhotra, D Kazakov, M Michal, SH Merchant, N Goldstein, M Amin - William Beaumont Hospital, Royal Oak, MI; University Hospital Plzen, Pilsen, Czech Republic; VA Hospital, Albuquerque, NM 37 Clinicopathologic and Immunohistochemical Features of Aggressive Cutaneous Squamous Cell Carcinomas (347) DO Christensen, AR Prasad - University of Arizona, SAVAHCS, Tucson, AZ 38 Decreased Srcasm Expression in Squamous Cell Carcinoma. (404) AK Witkiewicz, L Weijie, JT Seykora - University of Pennsylvania Medical School, Philadelphia, PA 39 The Role of FNA And Surgical Biopsy in the Evaluation of Scalp Lesions (358) KT Galan, P Gattuso, L Green, VB Reddy - Rush University Medical Center, Chicago, IL; VA Hospital, Houston, TX